Daunorubicin and ejection fraction decreased Patient Reports February 10, 2010

Daunorubicin Side Effects Report #4643325-7
Daunorubicin side effect was reported by a Health Professional from on Apr 04, 2005. Female patient, 86 years of age, weighting 105.0 lb, was diagnosed with acute myeloid leukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: acute pulmonary oedema, ejection fraction decreased, febrile neutropenia, fluid overload, heart rate increased, palpitations, platelet count decreased, staphylococcal sepsis. Daunorubicin dosage: 45 MG/M2 OTHER. During the same period patient was treated with NEUPOGEN. Patient was hospitalized. Patient recovered.

Daunorubicin Side Effects Report #4773149-1
Daunorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 15, 2005. Male patient, weighting 171.1 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, blood bilirubin increased, cholelithiasis, computerised tomogram abnormal, ejection fraction decreased, hemiparesis, hepatosplenic candidiasis, lung consolidation, lung infection. Daunorubicin dosage: unknown. During the same period patient was treated with VINCRISTINE SULPHATE, VINCRISTINE SULPHATE, PREDNISONE, METHOTREXATE. Patient was hospitalized. Patient recovered.

Daunorubicin Side Effects Report #4801407-0
Daunorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 11, 2005. Male patient, weighting 171.1 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: atelectasis, blood alkaline phosphatase increased, blood bilirubin increased, chest pain , cholelithiasis, computerised tomogram abnormal, ejection fraction decreased, hemiparesis, hepatosplenic candidiasis. Daunorubicin dosage: unknown. During the same period patient was treated with VINCRISTINE SULPHATE, PREDNISONE, METHOTREXATE. Patient was hospitalized. Patient recovered.

Daunorubicin Side Effects Report #4815451-0
Daunorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 27, 2005. Male patient, weighting 171.1 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: asthenia, atelectasis, blood bilirubin increased, chest pain , cholelithiasis, computerised tomogram abnormal, ejection fraction decreased, hepatosplenic candidiasis, infection . Daunorubicin dosage: unknown. During the same period patient was treated with VINCRISTINE SULPHATE, PREDNISONE, METHOTREXATE. Patient was hospitalized. Patient recovered.


Daunorubicin Side Effects Report #5787455-5
Daunorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on June 23, 2008. Male patient, weighting 197.1 lb, was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: ejection fraction decreased, ventricular dysfunction, ventricular failure. Daunorubicin dosage: 291 MG. Patient recovered.

Daunorubicin Side Effects Report #5793089-9
Daunorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on June 26, 2008. Male patient, weighting 198.6 lb, was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: ejection fraction decreased. Daunorubicin dosage: 279 MG. Patient recovered.

Daunorubicin Side Effects Report #5840239-1
Daunorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 07, 2008. Male patient, weighting 198.6 lb, was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: ejection fraction decreased. Daunorubicin dosage: 279 MG. Patient recovered.